ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,478.86
      -1.41%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Takeda Pharmaceutical Company Ltd (TAK)

      7. Takeda Pharmaceutical Company Ltd (TAK) News

      Takeda Pharmaceutical Company Ltd

      Takeda Pharmaceutical Company Ltd (TAK)

      Taku Gold Corp
      13.21
      0.10
      (0.76%)
      Closed July 07 4:00PM
      Delayed by 15 minutes
      13.21
      0.00
      (0.00%)
      After Hours: 4:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      TAK News

      Official News Only

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
      Edgar (US Regulatory)
      June 17 2024
      TAK (0.76%)

      TAK Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      TAK over $10
      👍️0
      Boing x 2 Boing x 2 1 year ago
      Just saying,

      https://www.takeda.com/newsroom/newsreleases/2022/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-us-food-and-drug-administration

      4 months or less until an answer. Expedited review is six months or less now. It was accepted Nov 22nd.

      Big if we get FDA apprvoval. ETF's in the know are sucking up shares.

      Other approved drug has serious side effects vs. ours.

      300M cases a year from mosquito bites.

      Boing X 2
      👍️0
      Phosphene Phosphene 4 years ago
      Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

      https://www.businesswire.com/news/home/20201208005955/en/Takeda%E2%80%99s-Pipeline-Has-Potential-to-Contribute-Significantly-to-Revenue-Growth-Over-Next-Decade
      👍️0
      Phosphene Phosphene 4 years ago
      Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO

      https://www.reuters.com/article/health-coronavirus-takeda-vaccines-idUSKBN27M0F7
      👍️0
      Phosphene Phosphene 4 years ago
      MIT-Takeda program launches

      Research projects will harness the power of artificial intelligence to positively impact human health.

      https://news.mit.edu/2020/mit-takeda-program-launches-research-ai-and-human-health-0618
      👍️0
      rising rising 6 years ago
      Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

      ADR is 3:1 - NICE!
      60 percent upside
      Added 36.83 US stock
      Added 29.38 US cash


      Not a bad deal!
      👍️0
      rising rising 6 years ago
      So how does the Shire shareholder make out on this deal?

      Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

      Where is the 60percent premium to Close of March 27 2018 at shire 128.87
      👍️0
      trendmkr trendmkr 8 years ago
      Takeda article: enGene Shines with a Host of Big Name Collaborations

      http://marketexclusive.com/engene-shines-with-a-host-of-big-name-collaborations/1281/
      👍️0

      Your Recent History

      NYSE
      TAK
      Takeda Pharmaceutical
      Delayed Upgrade Clock